Our earlier studies indicated that the proto-oncogene PELP1 promotes KDM1-driven epigenetic modifications leading to local estrogen synthesis, contributing to cancer cell proliferation and therapy resistance [19]. This evidence concerns the gene PELP1 and cancer.